564
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Tofacitinib for managing granuloma formation after dermal filler injection: three case reports and literature review

, , , &
Article: 2338281 | Received 27 Dec 2023, Accepted 28 Mar 2024, Published online: 18 Apr 2024

References

  • Dong J, Gantz M, Goldenberg G. Efficacy and safety of new dermal fillers. Cutis. 2016;98(5):1–6.
  • Oh H, Lee S, Na J, et al. Comparative evaluation of safety and efficacy of a novel hyaluronic acid-polynucleotide/poly-L-lactic acid composite dermal filler. Aesthetic Plast Surg. 2021;45(4):1792–1801. doi: 10.1007/s00266-021-02295-3.
  • Lee JM, Kim YJ. Foreign body granulomas after the use of dermal fillers: pathophysiology, clinical appearance, histologic features, and treatment. Arch Plast Surg. 2015;42(2):232–239. doi: 10.5999/aps.2015.42.2.232.
  • Lemperle G, Morhenn V, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthetic Plast Surg. 2020;44(4):1348–1360. doi: 10.1007/s00266-020-01827-7.
  • Ghareeb FM, Hassan MSA, El Nahas MA, et al. Complicated facial fillers: management algorithm. Plast Reconstr Surg Glob Open. 2022;10(7):e4445. doi: 10.1097/GOX.0000000000004445.
  • Owczarczyk-Saczonek A, De Boulle K. Hyaluronic acid fillers and ASIA syndrome: case studies. Clin Cosmet Investig Dermatol. 2023;16:2763–2771. [Published correction appears in Clin Cosmet Investig Dermatol. 2023 Nov 15;16:3321–3322]. doi: 10.2147/CCID.S419716.
  • Lucey P, Goldberg DJ. Complications of collagen fillers. Facial Plast Surg. 2014;30(6):615–622. doi: 10.1055/s-0034-1396904.
  • Lemperle G, Gauthier-Hazan N. Foreign body granulomas after all injectable dermal fillers: part 2. Treatment options. Plast Reconstr Surg. 2009;123(6):1864–1873. doi: 10.1097/PRS.0b013e3181858f4f.
  • Aivaliotis M, Kontochristopoulos G, Hatziolou E, et al. Successful colchicine administration in facial granulomas caused by cosmetic implants: report of a case. J Dermatolog Treat. 2007;18(2):112–114. doi: 10.1080/08910600601149619.
  • Lemperle G, Duffy DM. Treatment options for dermal filler complications. Aesthet Surg J. 2006;26(3):356–364. doi: 10.1016/j.asj.2006.04.002.
  • Ostezan L, Peck J. Radial sound (shockwave) therapy resolves delayed-onset nodules following injection of hyaluronic acid dermal filler: a case study. J Clin Aesthet Dermatol. 2021;14(12 Suppl 1):S15–S17.
  • Hong JK, Sun B, Shin SH, et al. Late-onset filler-induced granuloma after polycaprolactone-based filler treated with High-Intensity focused ultrasound and quantum molecular resonance technology. Dermatol Surg. 2022;48(6):693–694. doi: 10.1097/DSS.0000000000003424.
  • Bonnema H, Popa ER, van Timmeren MM, et al. Distribution patterns of the membrane glycoprotein CD44 during the foreign-body reaction to a degradable biomaterial in rats and mice. J Biomed Mater Res A. 2003;64(3):502–508. doi: 10.1002/jbm.a.10404.
  • Modarressi A, Nizet C, Lombardi T. Granulomas and nongranulomatous nodules after filler injection: different complications require different treatments. J Plast Reconstr Aesthet Surg. 2020;73(11):2010–2015. doi: 10.1016/j.bjps.2020.08.012.
  • Kunjur J, Witherow H. Long-term complications associated with permanent dermal fillers. Br J Oral Maxillofac Surg. 2013;51(8):858–862. doi: 10.1016/j.bjoms.2013.06.013.
  • Wang A, Singh K, Ibrahim W, et al. The promise of JAK inhibitors for treatment of sarcoidosis and other inflammatory disorders with macrophage activation: a review of the literature. Yale J Biol Med. 2020;93(1):187–195.
  • Damsky W, Thakral D, McGeary MK, et al. Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare. J Am Acad Dermatol. 2020;82(3):612–621. doi: 10.1016/j.jaad.2019.05.098.
  • Cohen Tervaert JW, Martinez-Lavin M, Jara LJ, et al. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023. Autoimmun Rev. 2023;22(5):103287. doi: 10.1016/j.autrev.2023.103287.